Daniël Hoyer

38.3k total citations · 6 hit papers
371 papers, 26.6k citations indexed

About

Daniël Hoyer is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Epidemiology. According to data from OpenAlex, Daniël Hoyer has authored 371 papers receiving a total of 26.6k indexed citations (citations by other indexed papers that have themselves been cited), including 214 papers in Molecular Biology, 149 papers in Cellular and Molecular Neuroscience and 76 papers in Epidemiology. Recurrent topics in Daniël Hoyer's work include Receptor Mechanisms and Signaling (135 papers), Neurotransmitter Receptor Influence on Behavior (83 papers) and Neuroscience and Neuropharmacology Research (77 papers). Daniël Hoyer is often cited by papers focused on Receptor Mechanisms and Signaling (135 papers), Neurotransmitter Receptor Influence on Behavior (83 papers) and Neuroscience and Neuropharmacology Research (77 papers). Daniël Hoyer collaborates with scholars based in Switzerland, United States and Australia. Daniël Hoyer's co-authors include Graeme R. Martin, Jason Hannon, Philippe Schoeffter, P.P.A. Humphrey, José Palacios, Paul Hartig, G. Engel, Ángel Pazos, Christian Waeber and John R. Fozard and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Daniël Hoyer

370 papers receiving 25.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).

1994 2.6k citations Daniël Hoyer, David E. Clarke et al. Pharmacological Reviews profile →
Molecular, pharmacological and functional diversity of 5-HT receptors

2002 1.5k citations Daniël Hoyer, Jason Hannon et al. profile →
Molecular biology of 5-HT receptors

2008 632 citations Jason Hannon, Daniël Hoyer profile →
An analysis of FDA-approved drugs: natural products and their derivatives

2015 610 citations Eric Patridge, Peter C. Gareiss et al. Drug Discovery Today profile →
Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain cortex with 5-HT1B binding sites

1986 586 citations Daniël Hoyer et al. Naunyn-Schmiedeberg s Archives of Pharmacology profile →
Functional Correlates of Serotonin 5-HT₁Recognition Sites

1988 520 citations Daniël Hoyer profile →

Peers

Countries citing papers authored by Daniël Hoyer

Since Specialization

Citations

This map shows the geographic impact of Daniël Hoyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniël Hoyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniël Hoyer more than expected).

Fields of papers citing papers by Daniël Hoyer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniël Hoyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniël Hoyer. The network helps show where Daniël Hoyer may publish in the future.

Co-authorship network of co-authors of Daniël Hoyer

This figure shows the co-authorship network connecting the top 25 collaborators of Daniël Hoyer. A scholar is included among the top collaborators of Daniël Hoyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniël Hoyer. Daniël Hoyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The distribution of Hypocretin/Orexin receptor mRNA in the mouse and human brain 2024 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Romke Bron, Cameron J. Nowell, Catriona McLean, (unknown), Laura J. Vella, Brian Dean, Daniël Hoyer, Laura H. Jacobson	2
2	Default Mode Network Modulation by Psychedelics: A Systematic Review 2022 ·The International Journal of Neuropsychopharmacology ·(unknown), Daniel Perkins, Simon Ruffell, Andrew J. Lawrence, Daniël Hoyer, Laura H. Jacobson, Christopher Timmermann, David Castle, Susan L. Rossell, Luke A. Downey, Broc A. Pagni, Nicole Leite Galvão‐Coelho, David Nutt, Jerome Sarris	112
3	Orexin receptors in GtoPdb v.2021.3 2021 ·IUPHAR/BPS Guide to Pharmacology CITE ·Paul J. Coleman, Luı́s de Lecea, Anthony L. Gotter, Jim J. Hagan, Daniël Hoyer, Thomas S. Kilduff, Jyrki P. Kukkonen, Rod A. Porter, John J. Renger, Jerome M. Siegel, (unknown), Neil Upton, Christopher J. Winrow	3
4	Manipulation of rapid eye movement sleep via orexin and GABAA receptor modulators differentially affects fear extinction in mice: effect of stable versus disrupted circadian rhythm 2021 ·SLEEP ·(unknown), (unknown), (unknown), (unknown), Daniël Hoyer, Sean P. A. Drummond, Laura H. Jacobson	10
5	A γ-lactam siderophore antibiotic effective against multidrug-resistant Pseudomonas aeruginosa, Klebsiella pneumoniae, and Acinetobacter spp. 2021 ·European Journal of Medicinal Chemistry ·Joel Goldberg, Vijay Kumar, (unknown), Daniël Hoyer, Steven H. Marshall, Andrea M. Hujer, Kristine M. Hujer, Christopher R. Bethel, Krisztina M. Papp‐Wallace, Federico Pérez, Michael R. Jacobs, David van Duin, Barry N. Kreiswirth, Focco van den Akker, Mark S. Plummer, Robert A. Bonomo	18
6	Sex differences in mouse models of fear inhibition: Fear extinction, safety learning, and fear–safety discrimination 2019 ·British Journal of Pharmacology ·(unknown), Sean P. A. Drummond, Daniël Hoyer, Laura H. Jacobson	41
7	Macrolides selectively inhibit mutant KCNJ5 potassium channels that cause aldosterone-producing adenoma 2017 ·Journal of Clinical Investigation ·Ute I. Scholl, Laura Abriola, Chengbiao Zhang, (unknown), Mark S. Plummer, Barbara I. Kazmierczak, Junhui Zhang, Daniël Hoyer, Jane S. Merkel, Wen‐Hui Wang, Richard P. Lifton	55
8	An analysis of FDA-approved drugs: natural products and their derivatives breakdown → 2015 ·Drug Discovery Today ·Eric Patridge, Peter C. Gareiss, Michael S. Kinch, Daniël Hoyer	610
9	The mTOR kinase inhibitor Everolimus decreases S6 kinase phosphorylation but fails to reduce mutant huntingtin levels in brain and is not neuroprotective in the R6/2 mouse model of Huntington's disease 2010 ·Molecular Neurodegeneration ·Jonathan H. Fox, (unknown), Vanita Chopra, (unknown), Jibrin Kama, Dorothée Bleckmann, Claudia Betschart, Daniël Hoyer, Stefan Frentzel, Marian DiFiglia, Paolo Paganetti, Steven M. Hersch	76
10	ABP688, a novel selective and high affinity ligand for the labeling of mGlu5 receptors: Identification, in vitro pharmacology, pharmacokinetic and biodistribution studies 2006 ·Bioorganic & Medicinal Chemistry ·Samuel Hintermann, Ivo Vranesic, Hans Allgeier, (unknown), Daniël Hoyer, Michel Lemaire, (unknown), Stephan Urwyler, Steven Whitebread, F. Gasparini, Yves P. Auberson	55
11	mGluR7 plays a key role in the modulation of anxiety behavior: Evidence from mGluR7-knockout mice and siRNA-induced knockdown in the adult mouse brain 2005 ·Neuropharmacology ·(unknown), Daniël Hoyer, Markus Schmutz, Ron Maier, François Natt, Dieter Hüsken, Gilles Sansig, Herman van der Putten, (unknown), (unknown)	3
12	Serotonin receptors and systems: endless diversity? 2002 ·Acta Biologica Szegediensis ·Jason Hannon, Daniël Hoyer	21
13	Functional expression and pharmacological characterisation of the goldfish somatostatin sst5 receptor 2001 ·British Journal of Pharmacology ·Caroline Nunn, Dominik Feuerbach, Xi Lin, Richard Peter, Daniël Hoyer	2
14	Distribution and characterisation of somatostatin receptor mRNA and binding sites in the brain and periphery 2000 ·Journal of Physiology-Paris ·Dominique Fehlmann, Daniel Langenegger, (unknown), Sandra Siehler, Dominik Feuerbach, Daniël Hoyer	75
15	Cloning, expression, functional coupling and pharmacological characterization of the rat dopamine D 4 receptor 2000 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·Lucien Gazi, Philippe Schoeffter, Caroline Nunn, (unknown), Daniël Hoyer, Dominik Feuerbach	20
16	Pharmacological profile of human 5-hydroxytryptamine 5-HT7 receptors expressed in insect cells using the baculovirus system 1997 ·British Journal of Pharmacology ·Daniël Hoyer, (unknown), J. Gregor Sutcliffe	1
17	The Elusive Nature of Cerebellar Somatostatin Receptors: Studies in Rat, Monkey and Human Cerebellum 1997 ·Journal of Receptors and Signal Transduction ·Charles Piwko, (unknown), A. Probst, Daniël Hoyer	11
18	Co-expression of somatostatin SSTR-3 and SSTR-4 receptor messenger RNAs in the rat brain 1995 ·Neuroscience ·J. Pérez, Daniël Hoyer	50
19	International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). breakdown → 1994 ·Pharmacological Reviews ·Daniël Hoyer, David E. Clarke, John R. Fozard, Paul Hartig, Graeme R. Martin, Ewan J. Mylecharane, P.R. Saxena, P.P.A. Humphrey	2558
20	(±)-Iodocyanopindolol (125 ICYP), a potent, highly specific ligand for β-adrenoceptors 1980 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·Günther Engel, Daniël Hoyer, R. Berthold, Henry R. Wagner	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact